I took the tablet after dinner and had mild stomach cramps the next morning. The itching settled over several days, but the household hygiene measures were more work than I expected.
Albendazole
Albendazole is a medicine for people with intestinal or tissue infections caused by parasitic worms. It helps clear susceptible worms by disrupting their microtubules and reducing their energy production.
Description
Albendazole is a broad-spectrum benzimidazole anthelmintic medication. Its active ingredient is albendazole, and it belongs to the benzimidazole class of anthelmintic medicines.
Composition
Albendazole contains albendazole; the dose is stated on the pack — follow the leaflet, and it is supplied as tablets.
Dosage and usage
The correct dose depends on the diagnosed infection. The dose is stated on the pack — follow the leaflet. Common clinical regimens include:
- Ascariasis: the dose is stated on the pack — follow the leaflet
- Hookworm infection: the dose is stated on the pack — follow the leaflet
- Trichuriasis: the dose is stated on the pack — follow the leaflet
- Pinworm disease: the dose is stated on the pack — follow the leaflet; repeat treatment may be used to address reinfection
- Neurocysticercosis: treatment according to body weight and specialist assessment
- Hydatid disease: treatment according to body weight and specialist assessment
- Strongyloidiasis: treatment duration varies and may require a different anthelmintic strategy
Children may need weight-based dosing, age-specific assessment, or a formulation that allows more accurate dose adjustment. Do not assume that the single-dose intestinal regimen applies to tissue infection.
Swallow the tablet with water. Some treatment protocols allow the tablet to be chewed or crushed, but this depends on the specific product instructions and the patient’s ability to swallow tablets. Avoid changing the prescribed schedule because symptoms improve quickly.
If a dose is missed, take it when remembered unless the next scheduled dose is close. Do not double the next dose. A missed dose during a multi-day course may reduce treatment exposure, so the prescriber may need to confirm how the course should continue.
How it works
The medicine acts by binding to parasite beta-tubulin. This interferes with microtubule formation, a process the worm needs for movement, nutrient absorption, cell division, and maintenance of its internal tissues. The parasite becomes immobilised and gradually dies or loses its ability to reproduce.
Albendazole sulfoxide circulates in the blood and can reach tissues, including the central nervous system. This property supports its use in neurocysticercosis and other infections where the parasites are outside the intestine.
The United States Food and Drug Administration prescribing information describes the pharmacology, indications, warnings, and monitoring requirements for albendazole treatment [1].
Indications
Clinical uses include:
- Ascariasis, caused by Ascaris lumbricoides
- Hookworm infection, caused by Ancylostoma or Necator species
- Pinworm disease, also called enterobiasis
- Strongyloidiasis in selected treatment protocols
- Trichuriasis caused by whipworm
- Neurocysticercosis caused by larval Taenia solium
- Hydatid disease caused by Echinococcus species
- Other helminth infections identified through clinical assessment and testing
Albendazole is useful against intestinal nematodes because the medicine reaches the gastrointestinal tract and interferes with the worm’s ability to maintain its internal cell structure. Tissue infections need longer regimens and closer clinical monitoring than uncomplicated intestinal infections.
Treatment of Intestinal Nematodes and Hookworm Infections
For several common intestinal infections, a single 400 mg dose is used in adults and children above the relevant age threshold. Some infections need repeated dosing or a longer course. Pinworm treatment may require a second dose after two weeks because the medicine targets worms more reliably than newly deposited eggs.
Hookworm infection can cause abdominal symptoms, reduced appetite, fatigue, and iron-deficiency anaemia. Treating the worm is only one part of care when anaemia is present; haemoglobin and iron status may also require assessment.
A stool examination can identify eggs or larvae, though the timing and number of samples affect the chance of detection. Strongyloidiasis needs careful attention because infection can persist for years and may become severe in people receiving corticosteroids or other immunosuppressive treatment.
Comparison
Albendazole, mebendazole, and ivermectin differ in absorption, tissue penetration, spectrum, and preferred clinical uses.
| Treatment | Main clinical distinction | Practical limitation |
|---|---|---|
| Albendazole | Broad benzimidazole activity with an active systemic metabolite | Longer courses require liver and blood monitoring |
| Mebendazole | Strong activity against several intestinal nematodes with limited systemic absorption | Less suitable for some tissue infections |
| Ivermectin | Important option for strongyloidiasis and selected ectoparasitic infections | Dosing and safety depend on weight, infection, and patient factors |
Albendazole is often selected when the diagnosis involves several intestinal worm species or when tissue penetration is needed. Mebendazole may be suitable for some intestinal infections, while ivermectin has a distinct role in strongyloidiasis.
The choice should reflect the confirmed or suspected parasite rather than the severity of symptoms alone. The European Medicines Agency describes benzimidazole safety considerations in product information and regulatory assessments for anthelmintic treatment [2].
Contraindications
Albendazole is not suitable for everyone. This medication is not for you if:
- You have had a serious allergic reaction to albendazole or another benzimidazole anthelmintic.
- You are pregnant unless a clinician has determined that treatment is necessary.
- You have active liver disease without appropriate clinical assessment.
- You are receiving a prolonged course and cannot complete the required blood-count or liver-function monitoring.
- The suspected condition is unrelated to a parasitic worm infection.
- You have neurocysticercosis with raised intracranial pressure or eye involvement that has not been assessed.
Interactions can occur with medicines that alter liver enzyme activity. Cimetidine, dexamethasone, and praziquantel can increase albendazole sulfoxide exposure, while enzyme-inducing medicines such as carbamazepine, phenytoin, and phenobarbital may reduce exposure. The importance of each interaction depends on dose and treatment duration.
When this is not for you
Pregnancy requires special care because safety data are limited, especially during the first trimester. People who could become pregnant may be advised to use reliable contraception during treatment and for the period specified by the prescriber.
Side effects
Short courses are often tolerated without serious problems. Reported side effects can include:
- Abdominal pain
- Nausea or vomiting
- Diarrhoea
- Headache
- Dizziness
- Temporary fatigue
- Mild elevation of liver enzymes
Abdominal symptoms can overlap with the original parasitic infection. Taking the tablet with food may reduce stomach upset, although the food effect also increases absorption.
Longer or higher-dose treatment can produce more significant reactions, including hepatitis, reduced white blood cell counts, reduced platelet counts, fever, hair thinning, or reversible liver enzyme abnormalities. Severe headache, confusion, seizures, visual changes, yellowing of the skin, dark urine, unusual bruising, or persistent fever require prompt medical assessment.
A practical detail is that liver injury may initially appear only in blood tests. Feeling well does not rule out abnormal liver enzymes during prolonged treatment.
Common mistakes
Several errors can reduce the chance of a good outcome:
- Using a single dose for an infection that needs a multi-day or weight-based course
- Taking a prolonged course without liver-function or blood-count monitoring
- Forgetting the repeat dose used in some pinworm protocols
- Treating abdominal pain as proof of worms without diagnostic assessment
- Ignoring possible household reinfection with pinworm
- Stopping a specialist course when symptoms improve
- Doubling a missed dose
- Failing to mention pregnancy, liver disease, or seizure history
- Combining albendazole with another anthelmintic without a defined clinical reason
What doctors say
In clinical practice, doctors usually begin by identifying the likely parasite and deciding whether the infection is intestinal or tissue-based. A single 400 mg dose may be suitable for some intestinal nematodes, while neurocysticercosis, hydatid disease, and persistent strongyloidiasis require different treatment plans.
Physicians also look for complications. Hookworm can contribute to iron-deficiency anaemia. Strongyloidiasis can become dangerous during corticosteroid treatment. Neurocysticercosis may involve inflammation, seizures, or raised intracranial pressure, so self-treatment is inappropriate in that setting.
One common clinical mistake is repeating albendazole because symptoms remain, without confirming whether the original diagnosis was correct. Another is treating one household member for pinworm while overlooking environmental reinfection.
Frequently asked questions
What is Albendazole used to treat?
Albendazole treats several parasitic worm infections, including ascariasis, hookworm infection, pinworm disease, trichuriasis, and selected tissue infections. The U.S. National Library of Medicine’s MedlinePlus albendazole information, accessed in 2025, describes its use against susceptible helminths. The exact regimen depends on the parasite and its location.
How does Albendazole work?
Albendazole interferes with parasite microtubules and prevents normal nutrient use and cellular maintenance. Its active metabolite, albendazole sulfoxide, contributes to activity against tissue parasites. The FDA prescribing information explains this benzimidazole mechanism in the clinical pharmacology material available in 2021.
Is one 400 mg tablet enough?
One 400 mg dose is used for several uncomplicated intestinal worm infections in adults and suitable children. It is not enough for every diagnosis; neurocysticercosis, hydatid disease, trichuriasis, and some persistent infections require different schedules. WHO treatment guidance published in 2017 separates preventive single-dose use from treatment of individual tissue or complicated infections.
Should Albendazole be taken with food?
Food affects albendazole absorption, and a meal containing fat can increase exposure to albendazole sulfoxide. This is useful for tissue infections, while the administration instructions for a simple intestinal regimen may differ. EMA product information for albendazole, published in 2020, describes food effects and systemic exposure as relevant pharmacokinetic considerations.
What happens if a dose is missed?
Take the missed dose when remembered unless the next scheduled dose is close. Do not take two doses together to compensate. Advice from the World Health Organization in 2017 supports completing the intended regimen while avoiding unnecessary extra dosing.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Albendazole: Reviews and Experiences
The first dose helped with the night-time itching. We were given a repeat plan two weeks later, and washing bedding became part of the routine. The symptoms did not disappear after one night.
I had nausea during the first two days and felt tired. Blood tests were arranged because the course was longer, and the symptoms improved after treatment ended.
The abdominal discomfort improved, but the tablet did not explain the cause of the symptoms on its own. Testing later showed that I needed a different treatment plan.
Sources
- U.S. Food and Drug Administration (2021). ALBENZA (albendazole) tablets, for oral use: Prescribing Information.
- European Medicines Agency (2020). Summary of Product Characteristics (SmPC) — albendazole.